Physician profile
Grace Lopez
NPI 1265614051
$436.70
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $66.51 · 2021: $101 · 2022: $113.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $157.85 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $79.29 | 2019 | |
| Urovant Sciences INC | $54.55 | 2022 | |
| Mallinckrodt Hospital Products INC. | $48.29 | 2020 | |
| Acacia Pharma INC | $32.20 | 2021 | |
| Baudax Bio INC. | $30.06 | 2021 | |
| Ambu INC. | $17.45 | 2022 | |
| Blue Earth Diagnostics | $17.01 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.